SCHEMBL4942898

SCHEMBL4942898

COC(=O)c1ccc(-c2cc(C)cc(C)c2)o1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 2/20 0.59
MAPT P10636 2/20 0.53
HTT P42858 2/20 0.50
SCN10A Q9Y5Y9 1/20 0.50
SETD7 Q8WTS6 1/20 0.49
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C19 P33261 1/20 0.47
ALDH1A1 P00352 4/20 0.46
CNR2 P34972 1/20 0.46
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CHRM5 P08912 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
GAA P10253 2/20 0.43
GLA P06280 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23091222 0.85 SLC9A1 (0.55) SLC9A1MAPTHTTSCN10AMEN1
SCHEMBL4943045 0.85 SLC9A1 (0.62) SLC9A1HTTSCN10ACYP1A2CYP2C19
SCHEMBL4943742 0.84 HTT (0.51) MAPTHTTSCN10ASETD7MEN1
SCHEMBL23091227 0.84 CYP1A2 (0.59) SLC9A1MAPTSCN10AMEN1KMT2A
SCHEMBL21981938 0.83 HTT (0.67) MAPTHTTSETD7MEN1KMT2A
SCHEMBL4942973 0.81 SLC9A1 (0.57) SLC9A1MAPTHTTSCN10ASETD7
SCHEMBL4945642 0.81 SLC9A1 (0.57) SLC9A1HTTSETD7MEN1KMT2A
SCHEMBL1143497 0.79 ALDH1A1 (0.50) MAPTHTTSCN10ASETD7MEN1
SCHEMBL3059132 0.79 ALDH1A1 (0.62) SLC9A1HTTSETD7MEN1KMT2A
Hydrochloric Acid SCHEMBL4912703 0.78 ALDH1A1 (0.49) MAPTHTTSCN10ASETD7MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351843-B2 Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-04-01 US disclosed
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them SLC9A1, NHERF1, SLC5A1 SLC9A1 1/4885MAPT 4846/4885HTT 405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.